Suppr超能文献

用于角膜交联的薄扩张性角膜的定制上皮清创术:上皮岛交联技术

Customized epithelial debridement for thin ectatic corneas undergoing corneal cross-linking: epithelial island cross-linking technique.

作者信息

Mazzotta Cosimo, Ramovecchi Vincenzo

机构信息

Unità Operativa Complessa di Oculistica, Siena University Hospital, Siena, Italy.

Unità Operativa Complessa di Oculistica, San Severino Marche Hospital, San Severino Marche, Italy.

出版信息

Clin Ophthalmol. 2014 Jul 17;8:1337-43. doi: 10.2147/OPTH.S66372. eCollection 2014.

Abstract

Thin corneas with a minimum corneal thickness less than 400 μm after epithelial removal represent a contraindication to standard epithelium-off cross-linking (CXL) treatment due to a significant endothelial cell density decrease and potentiality of permanent haze development. Preoperative swelling of the cornea with hypoosmolar riboflavin solutions broadens the spectrum of CXL indications to thin corneas. However the iatrogenic swelling effect might not be durable throughout the CXL procedure increasing the risk of postoperative complications. The transepithelial CXL technique proposed for thin corneas demonstrated poor clinical results and mid- to long-term keratoconus instability. The epithelial island CXL technique with customized pachymetry-guided epithelial debridement was evaluated by means of in vivo laser scanning confocal microscopy, corneal topography, and clinical examination in a 1-year follow-up, in order to assess if it may be considered an alternative surgical option for keratoconic patients with thin corneas undergoing corneal collagen CXL. According to our clinical and in-vivo micro-morphological results the technique results safe, and efficacious in stabilizing progressive keratoconus and may be considered a valid option in the treatment of thin ectatic corneas alone or in combination with hypoosmolar or dextran-free riboflavin solutions.

摘要

上皮去除后角膜厚度最小值小于400μm的薄角膜是标准的上皮下交联(CXL)治疗的禁忌证,因为这会导致内皮细胞密度显著降低,并有可能形成永久性 haze。用低渗核黄素溶液进行术前角膜肿胀可将CXL适应症范围扩大到薄角膜。然而,在整个CXL过程中,医源性肿胀效果可能不持久,从而增加术后并发症的风险。针对薄角膜提出的经上皮CXL技术临床效果不佳,且圆锥角膜中长期稳定性较差。采用定制的测厚引导上皮清创的上皮岛CXL技术,通过体内激光扫描共聚焦显微镜、角膜地形图和临床检查进行了1年的随访评估,以确定它是否可被视为圆锥角膜薄角膜患者接受角膜胶原CXL时的替代手术选择。根据我们的临床和体内微观形态学结果,该技术安全有效,可稳定进行性圆锥角膜,可被视为单独治疗薄扩张性角膜或与低渗或无右旋糖酐核黄素溶液联合使用的有效选择。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9af/4109632/e1a0bd3a260b/opth-8-1337Fig1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验